Prostatic Neoplasms: all 6,484 studies

Page 16 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVActive, not recruitingNCT04514484Phase 1Results posted
• Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPCActive, not recruitingNCT04506567Phase 1Results posted
• A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)Active, not recruitingNCT04497844Phase 3Results posted
• A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.CompletedNCT04495179Phase 2Results posted
• Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN DeficiencyActive, not recruitingNCT04493853Phase 3Results posted
• Transpelvic Magnetic Stimulation to Improve Urogenital FunctionCompletedNCT04488068Not applicableResults posted
• High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical ProstatectomyTerminatedNCT04461509Phase 2Results posted
• Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCActive, not recruitingNCT04446117Phase 3Results posted
• Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate CancerCompletedNCT04428203Phase 1Results posted
• Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 WeeksActive, not recruitingNCT04422132Phase 2Results posted
• Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate CancerCompletedNCT04408924Phase 2Results posted
• PROState Pathway Embedded Comparative TrialCompletedNCT04400656Results posted
• 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate CancerCompletedNCT04390880Phase 2Results posted
• PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)TerminatedNCT04382898Phase 1/2Results posted
• Streamlined Genetic Testing in Prostate CancerCompletedNCT04359758Not applicableResults posted
• Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramCompletedNCT04350788Not applicableResults posted
• Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamideCompletedNCT04335682Phase 2Results posted
• Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate CancerTerminatedNCT04298983Phase 2Results posted
• HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate CancerTerminatedNCT04264208Phase 2Results posted
• Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate CancerActive, not recruitingNCT04262154Phase 2Results posted
• A Study Comparing ARB With Radium-223 vs ARB Therapy With Placebo and the Effect Upon Survival for mCRPC PatientsTerminatedNCT04237584Phase 3Results posted
• Trial of NanoPac Focal Therapy for Prostate CancerTerminatedNCT04221828Phase 2Results posted
• PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate CancerCompletedNCT04220983Not applicableResults posted
• Addition of Opaganib to Androgen Antagonists in Patients With mCRPCCompletedNCT04207255Phase 2Results posted
• A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate CancerActive, not recruitingNCT04190446Phase 2Results posted
• Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer RecurrenceCompletedNCT04186845Phase 3Results posted
• Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.CompletedNCT04186819Phase 3Results posted
• The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate CancerCompletedNCT04179968Phase 2Results posted
• A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate CancerTerminatedNCT04179864Phase 1/2Results posted
• Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)CompletedNCT04179396Phase 1Results posted
• PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot StudyTerminatedNCT04176497Phase 2Results posted
• Prostate Cancer Detection Screening MRI ProtocolCompletedNCT04175730Not applicableResults posted
• ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate CancerTerminatedNCT04159896Phase 2Results posted
• Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)TerminatedNCT04157088Phase 2Results posted
• Soccer Intervention in Prostate Cancer SurvivorsCompletedNCT04144127Not applicableResults posted
• An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate CancerTerminatedNCT04134208Phase 4Results posted
• A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)CompletedNCT04108208Phase 4Results posted
• A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerCompletedNCT04100018Phase 3Results posted
• Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic ProstatectomyCompletedNCT04098809Not applicableResults posted
• pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate CancerActive, not recruitingNCT04090528Phase 2Results posted
• An Open-label, Phase II Study of AZD4635 in Patients With Prostate CancerCompletedNCT04089553Phase 2Results posted
• PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot StudyCompletedNCT04086966Phase 1Results posted
• Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyCompletedNCT04068896Phase 1/2Results posted
• Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyTerminatedNCT04066894Phase 2Results posted
• Comparative Health Research Outcomes of NOvel Surgery in Prostate CancerCompletedNCT04049747Not applicableResults posted
• RAdium-223 and SABR Versus SABR for Oligometastatic Prostate CancersCompletedNCT04037358Phase 2Results posted
• Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringCompletedNCT04037254Phase 1/2Results posted
• sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate CancerStatus unknownNCT04033432Phase 2Results posted
• Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsTerminatedNCT04030559Phase 2Results posted
• ModraDoc006/r vs Docetaxel IV in Metastatic Prostate CancerCompletedNCT04028388Phase 2Results posted
• Nivolumab in Biochemically Recurrent dMMR Prostate CancerCompletedNCT04019964Phase 2Results posted
• A Study of the Drugs Talazoparib and Temozolomide in Prostate CancerTerminatedNCT04019327Phase 1/2Results posted
• Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate CancerCompletedNCT04011410Phase 2Results posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate CancerTerminatedNCT03999515Phase 2Results posted
• Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate CancerCompletedNCT03995888Phase 1Results posted
• Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical ModelCompletedNCT03979079Results posted
• Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate CancerTerminatedNCT03964337Phase 2Results posted
• 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU TherapyCompletedNCT03949517Phase 1/2Results posted
• I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).CompletedNCT03939689Phase 2Results posted
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsCompletedNCT03935282Not applicableResults posted
• CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneCompletedNCT03934840Phase 2Results posted
• The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPCCompletedNCT03899467Phase 2Results posted
• Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate CancerTerminatedNCT03886493Phase 2Results posted
• PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT03873805Phase 1Results posted
• Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American MenCompletedNCT03869216Not applicableResults posted
• A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.CompletedNCT03840200Phase 1Results posted
• A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1TerminatedNCT03837353Phase 1/2Results posted
• Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel CombinationsCompletedNCT03835533Phase 1Results posted
• Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)CompletedNCT03834519Phase 3Results posted
• Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)CompletedNCT03834506Phase 3Results posted
• Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)TerminatedNCT03834493Phase 3Results posted
• Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate CancerTerminatedNCT03827473Phase 2Results posted
• A Trial of CTT1403 for Metastatic Castration Resistant Prostate CancerCompletedNCT03822871Phase 1Results posted
• Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate CancerCompletedNCT03822845Phase 2/3Results posted
• A Study of Olaparib and Durvalumab in Prostate CancerTerminatedNCT03810105Phase 2Results posted
• 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate CancerCompletedNCT03809078Phase 2Results posted
• A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryActive, not recruitingNCT03809000Phase 2Results posted
• The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate CancerActive, not recruitingNCT03808077Phase 2Results posted
• 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT03805594Phase 1Results posted
• Gallium-68 PSMA-11 PET Imaging in Prostate Cancer PatientsCompletedNCT03803475Phase 3Results posted
• Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate CancerCompletedNCT03796767Phase 2Results posted
• (SGB) in Men Treated for Prostate Cancer Improve Hot FlashesTerminatedNCT03796195Phase 4Results posted
• Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)Active, not recruitingNCT03787680Phase 2Results posted
• MRI Guided SBRT for Localized Prostate CancerActive, not recruitingNCT03778112Not applicableResults posted
• Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADTTerminatedNCT03777982Phase 3Results posted
• Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPCTerminatedNCT03770455Phase 2Results posted
• Urology San Antonio MRI/MicroUS ComparisonCompletedNCT03762616Not applicableResults posted
• GET FIT Prostate: A Randomized Controlled Exercise TrialCompletedNCT03741335Not applicableResults posted
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerCompletedNCT03739684Phase 3Results posted
• Trial of Community Health Worker-led Decision CoachingCompletedNCT03726320Not applicableResults posted
• Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed TherapyActive, not recruitingNCT03725761Phase 2Results posted
• Improving Quality of Life of Prostate Cancer Survivors With Androgen DeficiencyCompletedNCT03716739Phase 2Results posted
• Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination DeficiencyTerminatedNCT03712930Phase 2Results posted
• Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer PatientsTerminatedNCT03712371Phase 1/2Results posted
• Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the BoneCompletedNCT03707184Phase 2Results posted
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerActive, not recruitingNCT03706365Phase 2/3Results posted
• Prostate Cancer Screening Trial Using ImagingCompletedNCT03702439Results posted
• Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate CancerCompletedNCT03698370Phase 2Results posted
• MSG Use With 18F-DCFPyL PET/CT ImagingCompletedNCT03693742Not applicableResults posted

← Prostatic Neoplasms overview